Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K HEINRICH

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
Clinical Cardiology|August 1, 1982
Influence of ipratropiumbromide on heart rate and hemodynamics in patients with sinus bradycardiaD Kikis, H Esser, K Heinrich
Skin Pharmacology and Physiology|January 18, 2014
Influence of different cosmetic formulations on the human skin barrierK Heinrich, U Heinrich, H Tronnier
Biochemical Society Transactions|March 23, 2012
The mechanical properties of kinesin-1: a holistic approachGeorge M Jeppesen, J K Heinrich Hoerber
Case Reports in Veterinary Medicine|June 30, 2018
Benign Pigmented Dermal Basal Cell Tumor in a Namibian Cheetah (<i>Acinonyx jubatus</i>)Sonja K Heinrich, Bettina Wachter, Gudrun Wibbelt
Zeitschrift Fur Klinische Psychologie Und Psychotherapie|January 1, 1975
[Changes in the psychic factor structure of schizophrenics after release from the hospital]P Netter-Munkelt, H H Croy, K Heinrich
Archives of Toxicology|June 16, 2010
Determination of 2,5-toluylenediamine (2,5-TDA) and aromatic amines in urine after personal application of hair dyes: kinetics and dosesThomas Schettgen, K Heinrich, T Kraus, et al.
Pharmacopsychiatry|January 1, 1990
Double-blind study of the therapeutic efficacy and tolerability of amitriptylinoxide in comparison with amitriptylineJ Tegeler, E Klieser, E Lehmann, et al.
Canadian Journal of Microbiology|March 23, 2001
Early production of rhizopine in nodules induced by Sinorhizobium meliloti strain L5-30K Heinrich, M H Ryder, P J Murphy
Pharmacopsychiatry|November 1, 1990
Safety of long-term neuroleptanxiolysis with fluspirilene 1.5 mg per weekJ Tegeler, E Lehmann, A Weiher, et al.
Expert Opinion on Drug Discovery|March 19, 2013
Protein silencing with Phylomers: a new tool for target validation and generating lead biologicals targeting protein interactionsPaul M Watt, Tatjana K Heinrich, Wayne R Thomas
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
Clinical Cardiology|August 1, 1982
Influence of ipratropiumbromide on heart rate and hemodynamics in patients with sinus bradycardiaD Kikis, H Esser, K Heinrich
Skin Pharmacology and Physiology|January 18, 2014
Influence of different cosmetic formulations on the human skin barrierK Heinrich, U Heinrich, H Tronnier
Biochemical Society Transactions|March 23, 2012
The mechanical properties of kinesin-1: a holistic approachGeorge M Jeppesen, J K Heinrich Hoerber
Case Reports in Veterinary Medicine|June 30, 2018
Benign Pigmented Dermal Basal Cell Tumor in a Namibian Cheetah (<i>Acinonyx jubatus</i>)Sonja K Heinrich, Bettina Wachter, Gudrun Wibbelt
Zeitschrift Fur Klinische Psychologie Und Psychotherapie|January 1, 1975
[Changes in the psychic factor structure of schizophrenics after release from the hospital]P Netter-Munkelt, H H Croy, K Heinrich
Archives of Toxicology|June 16, 2010
Determination of 2,5-toluylenediamine (2,5-TDA) and aromatic amines in urine after personal application of hair dyes: kinetics and dosesThomas Schettgen, K Heinrich, T Kraus, et al.
Pharmacopsychiatry|January 1, 1990
Double-blind study of the therapeutic efficacy and tolerability of amitriptylinoxide in comparison with amitriptylineJ Tegeler, E Klieser, E Lehmann, et al.
Canadian Journal of Microbiology|March 23, 2001
Early production of rhizopine in nodules induced by Sinorhizobium meliloti strain L5-30K Heinrich, M H Ryder, P J Murphy
Pharmacopsychiatry|November 1, 1990
Safety of long-term neuroleptanxiolysis with fluspirilene 1.5 mg per weekJ Tegeler, E Lehmann, A Weiher, et al.
Expert Opinion on Drug Discovery|March 19, 2013
Protein silencing with Phylomers: a new tool for target validation and generating lead biologicals targeting protein interactionsPaul M Watt, Tatjana K Heinrich, Wayne R Thomas
Pageof 12